Back
Speaker illustration

Mr Mauro Trincado Ave

University Hospital of Santiago de Compostela, Santiago de Compostela (Spain)

Presentations Articles

Joint relevance of CYP2D6 and H558R in the efficacy and toxicity of flecainide in patients with atrial fibrillation: a cohort study.

Event: ESC Congress 2025

Topic: Antiarrhythmic Drug Treatment

Session: Treatment of atrial fibrillation: there is more than ablation

Access
Like
Thumbnail

H558R: a common polymorphism may modify the efficacy and toxicity of flecainide in maintaining sinus rhythm; a cohort study.

Event: ESC Congress 2024

Topic: Rhythm Control, Antiarrhythmic Drugs

Session: Rhythm control in atrial fibrillation: prognostic and therapeutic implications

Access
Like
Thumbnail

Do CYP2D6 polymorphisms affect the efficacy and toxicity of flecainide? A cohort study.

Event: ESC Congress 2024

Topic: Rhythm Control, Antiarrhythmic Drugs

Session: Rhythm control in atrial fibrillation: prognostic and therapeutic implications

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources